HPGC Renmintongtai Pharmaceutical (SHSE:600829) Inventories, Finished Goods: ¥1,209 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600829 HPGC Renmintongtai Pharmaceutical Corp SHSE:600829
66 GF Score
Price ¥11.83
GF Value ¥8.13
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is HPGC Renmintongtai Pharmaceutical Inventories, Finished Goods?

HPGC Renmintongtai Pharmaceutical SHSE:600829 +10.05% 66 Inventories, Finished Goods is ¥1,209 Mil as of Jun. 2026. GuruFocus rates SHSE:600829 with a GF Score™ of 66/100 and a GF Value™ of ¥8.13 (Significantly Overvalued). The stock has 2 warning signs investors should review.

HPGC Renmintongtai Pharmaceutical's quarterly finished goods declined from Dec. 2025 (¥1,229 Mil) to Mar. 2026 (¥0 Mil) but then increased from Mar. 2026 (¥0 Mil) to Jun. 2026 (¥1,209 Mil).

HPGC Renmintongtai Pharmaceutical's annual finished goods declined from Dec. 2023 (¥1,113 Mil) to Dec. 2024 (¥1,100 Mil) but then increased from Dec. 2024 (¥1,100 Mil) to Dec. 2025 (¥1,229 Mil).

HPGC Renmintongtai Pharmaceutical Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for HPGC Renmintongtai Pharmaceutical's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HPGC Renmintongtai Pharmaceutical Inventories, Finished Goods Chart

HPGC Renmintongtai Pharmaceutical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,102.47 1,071.33 1,112.94 1,099.60 1,228.84

HPGC Renmintongtai Pharmaceutical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,075.71 0.00 1,228.84 0.00 1,208.93
SHSE:600829
66GF Score
HPGC Renmintongtai Pharmaceutical Corp SHSE:600829
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HPGC Renmintongtai Pharmaceutical Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ¥1,209 Mil mean?
HPGC Renmintongtai Pharmaceutical (SHSE:600829) has a Inventories, Finished Goods of ¥1,209 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on HPGC Renmintongtai Pharmaceutical and its competitors.
Is HPGC Renmintongtai Pharmaceutical's Inventories, Finished Goods too high?
HPGC Renmintongtai Pharmaceutical's current Inventories, Finished Goods is ¥1,209 Mil. Overall, HPGC Renmintongtai Pharmaceutical has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HPGC Renmintongtai Pharmaceutical's Inventories, Finished Goods compare to ZTS?
HPGC Renmintongtai Pharmaceutical's Inventories, Finished Goods of ¥1,209 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on HPGC Renmintongtai Pharmaceutical and its competitors. HPGC Renmintongtai Pharmaceutical's current Inventories, Finished Goods is ¥1,209 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HPGC Renmintongtai Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, HPGC Renmintongtai Pharmaceutical (SHSE:600829) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.13, compared to a current price of ¥11.83 — trading 45.5% above its estimated fair value. The current Inventories, Finished Goods is ¥1,209 Mil. HPGC Renmintongtai Pharmaceutical's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For HPGC Renmintongtai Pharmaceutical (SHSE:600829), the current Inventories, Finished Goods is ¥1,209 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HPGC Renmintongtai Pharmaceutical (SHSE:600829) Overvalued in 2026?

Based on GuruFocus' analysis, HPGC Renmintongtai Pharmaceutical stock appears to be overvalued. The current stock price of ¥11.83 is trading 45.5% above its estimated GF Value™ of ¥8.13. GuruFocus considers HPGC Renmintongtai Pharmaceutical to be Significantly Overvalued.

Key valuation signals for SHSE:600829:

  • Inventories, Finished Goods: ¥1,209 Mil
  • GF Value™: ¥8.13 vs. price of ¥11.83 (45.5% above fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600829 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HPGC Renmintongtai Pharmaceutical Business Description

Address No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
66GF Score

Get the complete analysis for SHSE:600829

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.83
Price
¥8.13
GF Value